chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, Interchange of vaccine products, SARS-CoV-2 test
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; Dose Number: 1 J and J, Dose Number 2, 3, 4: Pfizer / BioNTech; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 16Sep2022 at 09:00 as dose 4 (booster), single (Lot number: GH694) at the age of 63 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 07Nov2021 at 15:00 as dose 2, single (Lot number: FH8020), in left arm and on 23Apr2022 at 13:00 as dose 3 (booster), single (Lot number: FK9894), in left arm for covid-19 immunisation; coviD-19 vaccine nrvv ad26 (jnj 78436735) (JANSSEN COVID-19 VACCINE), on 06Mar2021 at 13:00 as dose 1, single (Lot number: 1805022), in left arm for covid-19 immunisation. The patient's relevant medical history included: "MS" (unspecified if ongoing); "Sicca Syndrome" (unspecified if ongoing); "iGg subclass degiciencies" (unspecified if ongoing), notes: iGg subclass degiciencies; "known allergies: Penicillin Allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 07Nov2021, outcome "unknown", described as "Dose Number: 1 J and J, Dose Number 2, 3, 4: Pfizer / BioNTech"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.Paxlovid was given from 30Jan2023 to 03Feb2023.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old male patient received BNT162b2 (BNT162B2), on 17Jun2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 52 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "HBP" (unspecified if ongoing); "Overweight" (unspecified if ongoing); "TAA (heart)" (unspecified if ongoing). The patient's concomitant medications were not reported. No other medication received in 2 weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid taken from 01Feb2023 to 06Feb2023.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 15Sep2022 as dose 4 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "IgA nephropathy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 from 30Jan2023 to 04Feb2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 72-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 01Nov2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 71 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Coronary artery disease" (unspecified if ongoing); "hx of afib" (unspecified if ongoing), notes: hx of afib. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Feb2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2, BNT162B2 OMI BA.4-5 to the drug ineffective (LOE) and COVID-19 cannot be ruled out.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Dec2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 44 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetic" (unspecified if ongoing); "thyroid issues" (unspecified if ongoing), notes: thyroid issues; "obesity" (unspecified if ongoing); "chronic pain" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Lyrica, reaction(s): "Known allergies: Lyrica", notes: Known allergies: Lyrica; Gabapentin, reaction(s): "Known allergies: Gabapentin", notes: Known allergies: Gabapentin; Bisoprol, reaction(s): "Known allergies: Bisoprol", notes: Known allergies: Bisoprol; Lisinopril, reaction(s): "Known allergies: Lisinopril", notes: Known allergies: Lisinopril; Salmeterol inhaler, reaction(s): "Known allergies: Salmeterol inhaler", notes: Known allergies: Salmeterol inhaler. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Feb2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 13-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Sep2022 as dose 4 (booster), single (Lot number: GJ5342) at the age of 13 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 23Jun2021 as dose 1, single (Lot number: EW0191), on 14Jul2021 as dose 2, single (Lot number: EW0198) and on 20Jan2022 as dose 3 (booster), single (Lot number: FK9729) for covid-19 immunisation. The patient's relevant medical history included: "Type 1 diabetes" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment; Negative, notes: Covid positive at home test after previous negative test; Positive, notes: Covid positive at home test after previous negative test. Therapeutic measures were taken as a result of vaccination failure, covid-19.
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Neuralgia
Clinical narrative: my legs are like bubbling like in a hot tub; nerves have never stopped; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 70-year-old female patient received BNT162b2 (BNT162B2), in 2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIMB DISCOMFORT (non-serious) with onset Mar2021, outcome "unknown", described as "my legs are like bubbling like in a hot tub"; NEURALGIA (non-serious) with onset Mar2021, outcome "not recovered", described as "nerves have never stopped".  Additional information: Patient took the two covid vaccine almost 3 years ago, in march two days after the vaccine and I didn't know it was yours it was Pfizer and the day after I took it, I went to the doctor because my legs maybe I should have called you about that a long time ago but my legs are like bubbling like in a hot tub and like little pop all over the place I called it like 'popcorn'. The nerves have never stopped since that time they're like the feeling that it is, Because of that concern I am concerned about taking the Paxlovid   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Limb discomfort, Neuralgia
Clinical narrative: my legs are like bubbling like in a hot tub; nerves have never stopped; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization, reaction(s): "my legs are like bubbling like in a hot tub", "'nerves have never stopped". The following information was reported: NEURALGIA (non-serious) with onset Mar2021, outcome "not recovered", described as "nerves have never stopped"; LIMB DISCOMFORT (non-serious), outcome "unknown", described as "my legs are like bubbling like in a hot tub". The events "my legs are like bubbling like in a hot tub" and "nerves have never stopped" required physician office visit.  Additional information: Patient took the two covid vaccine almost 3 years ago, in Mar two days after the vaccine and patient didn't know it was yours it was Pfizer and the day after she took it, she went to the doctor because her legs maybe patient should have called you about that a long time ago but her legs are like bubbling like in a hot tub and like little pop all over the place i called it like 'popcorn' . The nerves have never stopped since that time they're like the feeling that it is, Because of that concern patient concerned about taking the Paxlovid patient called the neurologist that patient go to and she didn't tell problem, but patient told them that her legs stopped doing that nerve issues since Mar2021, so it's not a hurting nerve issue. Caller stated "I did not take the booster because my doctor because the doctor questioned taking that because my nerves. and i didn't took a shingle issue and it's not shingle either.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: my legs are like bubbling like in a hot tub; nerves have never stopped; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization, reaction(s): "my legs are like bubbling like in a hot tub", "'nerves have never stopped". The following information was reported: NEURALGIA (non-serious) with onset Mar2021, outcome "not recovered", described as "nerves have never stopped"; LIMB DISCOMFORT (non-serious), outcome "unknown", described as "my legs are like bubbling like in a hot tub". The events "my legs are like bubbling like in a hot tub" and "nerves have never stopped" required physician office visit.  Additional information: Patient took the two covid vaccine almost 3 years ago, in Mar two days after the vaccine and patient didn't know it was yours it was Pfizer and the day after she took it, she went to the doctor because her legs maybe patient should have called you about that a long time ago but her legs are like bubbling like in a hot tub and like little pop all over the place i called it like 'popcorn' . The nerves have never stopped since that time they're like the feeling that it is, Because of that concern patient concerned about taking the Paxlovid patient called the neurologist that patient go to and she didn't tell problem, but patient told them that her legs stopped doing that nerve issues since Mar2021, so it's not a hurting nerve issue. Caller stated "I did not take the booster because my doctor because the doctor questioned taking that because my nerves. and i didn't took a shingle issue and it's not shingle either.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Limb discomfort, Neuralgia
Clinical narrative: Taking the Paxlovid; Taking the Paxlovid; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 70-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Taking the Paxlovid". Therapeutic measures were taken as a result of drug ineffective, COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Taking the Paxlovid; Taking the Paxlovid; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 70-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Taking the Paxlovid". Therapeutic measures were taken as a result of drug ineffective, COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Sep2022 at 09:00 as dose 5 (booster), single (Lot number: GH9694) at the age of 66 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 04Apr2022 as dose 4 (booster), single (Lot number: FJ9943), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 which includes Paxlovid from 13Jan2023 to 28Jan2023.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Paxlovid as Treatment of COVID-19; Paxlovid as Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 01Nov2022 at 12:00 as dose 6 (booster), single (Lot number: GJ3275) at the age of 69 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 05Mar2021 at 10:00 as dose 1, single (Lot number: EN6205), in left arm, on 26Mar2021 at 10:15 as dose 2, single (Lot number: ER8732), in left arm, on 18Aug2021 at 09:30 as dose 3 (booster), single (Lot number: FC3180), in left arm, on 24Jan2022 at 13:00 as dose 4 (booster), single (Lot number: 33025BD), in right arm and on 13Jun2022 at 10:00 as dose 5 (booster), single (Lot number: FN2908), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Sarcoidosis" (unspecified if ongoing); "High Blood Pressure" (unspecified if ongoing); "Hypothyroidism" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Diltiazem, reaction(s): "Known allergies: Diltiazem"; Lisinopril, reaction(s): "Known allergies: Lisinopril". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "Paxlovid as Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 including Paxlovid from 31Jan2023 to 05Feb2023.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: short lived axillary adenopathy; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 73-year-old male patient received BNT162b2 (BNT162B2), on 11Jan2021 as dose 1, single (Lot number: EN6201) at the age of 71 years intramuscular, in left deltoid for covid-19 immunisation. The patient's relevant medical history included: "Adult onset atopic dermatitis", start date: 01Jan2012 (unspecified if ongoing), notes: Treated with various beam UVB. Concomitant medication(s) included: TRIAMCINOLONE; CETAPHIL [CETYL ALCOHOL;SODIUM LAURYL SULFATE;STEARYL ALCOHOL]. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "short lived axillary adenopathy".  Clinical Course: Only side effect from vaccine was short lived axillary adenopathy or the side of the injection. Sender's Comments: Linked Report(s): PFIZER INC-202300066388 same patient and event, different dose number; PFIZER INC-202300066386 same patient and event, different dose number. PFIZER INC-202300066387 same patient and event, different dose number;
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: short lived axillary adenopathy; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 73-year-old male patient received BNT162b2 (BNT162B2), on 28Sep2021 as dose 3 (booster), single (Lot number: 301558A) at the age of 72 years intramuscular, in left deltoid for covid-19 immunisation. The patient's relevant medical history included: "Adult onset atopic dermatitis", start date: 01Jan2012 (unspecified if ongoing), notes: Pertinent details: Treated with narrow beam UVB. Concomitant medication(s) included: TRIAMCINOLONE; CETAPHIL [CETYL ALCOHOL;SODIUM LAURYL SULFATE;STEARYL ALCOHOL]. Vaccination history included: BNT162b2 (Dose: 1st, Date: 11Jan2021, Site and route of injection:, Anatomical site of injection: Left deltoid, Route of administration: Intramuscular, Batch/Lot number: EN6201), administration date: 11Jan2021, when the patient was 71-year-old, for COVID-19 immunization, reaction(s): "short lived apillary"; BNT162b2 (Dose: 2nd , Date: 04Mar2021, Site and route of injection:, Anatomical site of injection: Left deltoid, Route of administration: Intramuscular, Batch/Lot number: EN6201), administration date: 04Mar2021, when the patient was 71-year-old, for COVID-19 immunization, reaction(s): "1st dose: 11Jan2021; 2nd dose: 04Mar2021". The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "short lived axillary adenopathy".  Additional information: Only side effect from vaccine was short lived apillary adenopathy or the side of the injection.; Sender's Comments: Linked Report(s) : PFIZER INC-202300066370 same patient and event, different dose number.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Abnormal behaviour, Aggression, Confusional state, Crime, Feeling abnormal
Clinical narrative: I was forced by my employer to take the new, untested, MODERNA mRNA, 2 shot series, IM 'vaccine' or "be terminated". I reluctantly allowed healthcare staff to administer the two part shot series. I immediately began having NEGATIVE PSYCHIATRIC side effects following the second shot in the series. Both shots were administered at facility.'  Adverse effects included: 1. Psychosis (as exhibited for the first time in my life) 2. Paranoia (as exhibited for the first time in my life) 3. Irrational Thoughts/Irrational Behaviors (as exhibited for the first time in my life) 4. I became argumentative. I had increased aggressive behaviors. (as exhibited for the first time in my life) 5. Bizarre Behaviors to manifest and spiral out of control by March/April 2021. I was terminated after I created a detailed account of leadership exercising persecution and abuse that was directed at me. I blamed leadership of being sexist and not promoting me simply because I was a male RN in a female dominated profession. I forwarded my concerns to HR and subsequently she took my complaints to leadership.  I was eventually placed on PRN Clonazepam in the fall of 2021, by my PCP. I was placed on this medication: due to disturbing thoughts, and negative emotions not subsiding, as well as newly formed: Night terrors and PTSD flashback events. Dr. has a detailed record of my medical and mental history dating back to 2020.  By the end of 2022, my memory had become foggy/dementia like, and my dreams versus reality became unclear. By the end of 2022/2023, I had been fired by another employer due to 'no call no shows' (which is opposite of who I am)  I was arrested in November 2022 for bizarre, menacing behavior exhibited outside a person's home. I was confused and couldn't comply with any police commands during my arrest. I was "almost shot" by multiple police even though I had my back to the police and was on my knees but was confused and non-compliant as stated by police officer during my booking and subsequent jail sentence. I was charged with Misdemeanor for that crime. I was again arrested in February 2023 for crime that I committed in November 2022. A crime I had only faint memory of: Breaking and Entering & Theft. I was charged with two FELONY 4's as a result and jailed.  As of this writing, I am under house arrest and being monitored.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Impaired work ability, Imprisonment, Laboratory test, Memory impairment
Clinical narrative: I was forced by my employer to take the new, untested, MODERNA mRNA, 2 shot series, IM 'vaccine' or "be terminated". I reluctantly allowed healthcare staff to administer the two part shot series. I immediately began having NEGATIVE PSYCHIATRIC side effects following the second shot in the series. Both shots were administered at facility.'  Adverse effects included: 1. Psychosis (as exhibited for the first time in my life) 2. Paranoia (as exhibited for the first time in my life) 3. Irrational Thoughts/Irrational Behaviors (as exhibited for the first time in my life) 4. I became argumentative. I had increased aggressive behaviors. (as exhibited for the first time in my life) 5. Bizarre Behaviors to manifest and spiral out of control by March/April 2021. I was terminated after I created a detailed account of leadership exercising persecution and abuse that was directed at me. I blamed leadership of being sexist and not promoting me simply because I was a male RN in a female dominated profession. I forwarded my concerns to HR and subsequently she took my complaints to leadership.  I was eventually placed on PRN Clonazepam in the fall of 2021, by my PCP. I was placed on this medication: due to disturbing thoughts, and negative emotions not subsiding, as well as newly formed: Night terrors and PTSD flashback events. Dr. has a detailed record of my medical and mental history dating back to 2020.  By the end of 2022, my memory had become foggy/dementia like, and my dreams versus reality became unclear. By the end of 2022/2023, I had been fired by another employer due to 'no call no shows' (which is opposite of who I am)  I was arrested in November 2022 for bizarre, menacing behavior exhibited outside a person's home. I was confused and couldn't comply with any police commands during my arrest. I was "almost shot" by multiple police even though I had my back to the police and was on my knees but was confused and non-compliant as stated by police officer during my booking and subsequent jail sentence. I was charged with Misdemeanor for that crime. I was again arrested in February 2023 for crime that I committed in November 2022. A crime I had only faint memory of: Breaking and Entering & Theft. I was charged with two FELONY 4's as a result and jailed.  As of this writing, I am under house arrest and being monitored.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Paranoia, Post-traumatic stress disorder, Psychotic disorder, Sinusitis, Sleep terror
Clinical narrative: I was forced by my employer to take the new, untested, MODERNA mRNA, 2 shot series, IM 'vaccine' or "be terminated". I reluctantly allowed healthcare staff to administer the two part shot series. I immediately began having NEGATIVE PSYCHIATRIC side effects following the second shot in the series. Both shots were administered at facility.'  Adverse effects included: 1. Psychosis (as exhibited for the first time in my life) 2. Paranoia (as exhibited for the first time in my life) 3. Irrational Thoughts/Irrational Behaviors (as exhibited for the first time in my life) 4. I became argumentative. I had increased aggressive behaviors. (as exhibited for the first time in my life) 5. Bizarre Behaviors to manifest and spiral out of control by March/April 2021. I was terminated after I created a detailed account of leadership exercising persecution and abuse that was directed at me. I blamed leadership of being sexist and not promoting me simply because I was a male RN in a female dominated profession. I forwarded my concerns to HR and subsequently she took my complaints to leadership.  I was eventually placed on PRN Clonazepam in the fall of 2021, by my PCP. I was placed on this medication: due to disturbing thoughts, and negative emotions not subsiding, as well as newly formed: Night terrors and PTSD flashback events. Dr. has a detailed record of my medical and mental history dating back to 2020.  By the end of 2022, my memory had become foggy/dementia like, and my dreams versus reality became unclear. By the end of 2022/2023, I had been fired by another employer due to 'no call no shows' (which is opposite of who I am)  I was arrested in November 2022 for bizarre, menacing behavior exhibited outside a person's home. I was confused and couldn't comply with any police commands during my arrest. I was "almost shot" by multiple police even though I had my back to the police and was on my knees but was confused and non-compliant as stated by police officer during my booking and subsequent jail sentence. I was charged with Misdemeanor for that crime. I was again arrested in February 2023 for crime that I committed in November 2022. A crime I had only faint memory of: Breaking and Entering & Theft. I was charged with two FELONY 4's as a result and jailed.  As of this writing, I am under house arrest and being monitored.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Thinking abnormal
Clinical narrative: I was forced by my employer to take the new, untested, MODERNA mRNA, 2 shot series, IM 'vaccine' or "be terminated". I reluctantly allowed healthcare staff to administer the two part shot series. I immediately began having NEGATIVE PSYCHIATRIC side effects following the second shot in the series. Both shots were administered at facility.'  Adverse effects included: 1. Psychosis (as exhibited for the first time in my life) 2. Paranoia (as exhibited for the first time in my life) 3. Irrational Thoughts/Irrational Behaviors (as exhibited for the first time in my life) 4. I became argumentative. I had increased aggressive behaviors. (as exhibited for the first time in my life) 5. Bizarre Behaviors to manifest and spiral out of control by March/April 2021. I was terminated after I created a detailed account of leadership exercising persecution and abuse that was directed at me. I blamed leadership of being sexist and not promoting me simply because I was a male RN in a female dominated profession. I forwarded my concerns to HR and subsequently she took my complaints to leadership.  I was eventually placed on PRN Clonazepam in the fall of 2021, by my PCP. I was placed on this medication: due to disturbing thoughts, and negative emotions not subsiding, as well as newly formed: Night terrors and PTSD flashback events. Dr. has a detailed record of my medical and mental history dating back to 2020.  By the end of 2022, my memory had become foggy/dementia like, and my dreams versus reality became unclear. By the end of 2022/2023, I had been fired by another employer due to 'no call no shows' (which is opposite of who I am)  I was arrested in November 2022 for bizarre, menacing behavior exhibited outside a person's home. I was confused and couldn't comply with any police commands during my arrest. I was "almost shot" by multiple police even though I had my back to the police and was on my knees but was confused and non-compliant as stated by police officer during my booking and subsequent jail sentence. I was charged with Misdemeanor for that crime. I was again arrested in February 2023 for crime that I committed in November 2022. A crime I had only faint memory of: Breaking and Entering & Theft. I was charged with two FELONY 4's as a result and jailed.  As of this writing, I am under house arrest and being monitored.
Age: 88.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acquired haemophilia, Contusion, Death, Haematocrit decreased, Hypotension
Clinical narrative: patient develop severe bruising not caused by trauma a few weeks after vaccine. Went to urgent care and PCP, they all couldn't determine what is the cause.  later was hospitalize due to low hematocrit showing up on a recently labwork in january 2023 and was given blood transfusion. discharged because they  could not determine what the cause was but ruled out internal bleeding.  Went again to the hospital a few weeks later for low hematocrit and blood pressure, Diagnosed with acquired hemophilia, then passed away shortly after diagnosis.  never had any other autoimmune situation before and no recent medicine change.
Age: 88.0
Sex: F
Vaccine: COVID19-2
Symptoms: Laboratory test abnormal, Transfusion, Ultrasound scan normal
Clinical narrative: patient develop severe bruising not caused by trauma a few weeks after vaccine. Went to urgent care and PCP, they all couldn't determine what is the cause.  later was hospitalize due to low hematocrit showing up on a recently labwork in january 2023 and was given blood transfusion. discharged because they  could not determine what the cause was but ruled out internal bleeding.  Went again to the hospital a few weeks later for low hematocrit and blood pressure, Diagnosed with acquired hemophilia, then passed away shortly after diagnosis.  never had any other autoimmune situation before and no recent medicine change.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: short lived apillary adenopathy; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 73-year-old male patient received BNT162b2 (BNT162B2), on 04Apr2022 as dose 4 (booster), single (Lot number: FK9895) at the age of 72 years intramuscular, in left deltoid for covid-19 immunisation. The patient's relevant medical history included: "Adult onset atopic dermatitis", start date: 01Jan2012 (unspecified if ongoing), notes: Pertinent details: Treated with various beam UVB. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose: 1st, Date: 11Jan2021, Site and route of injection:, Anatomical site of injection: Left deltoid, Route of administration: Intramuscular, Batch/Lot number: EN6201), administration date: 11Jan2021, when the patient was 71-year-old, for COVID-19 immunization, reaction(s): "short lived apillary adenopathy"; BNT162b2 (Dose: 2nd , Date: 04Mar2021, Site and route of injection:, Anatomical site of injection: Left deltoid, Route of administration: Intramuscular, Batch/Lot number: EN6201), administration date: 04Mar2021, when the patient was 71-year-old, for COVID-19 immunization, reaction(s): "short lived apillary adenopathy", "1st dose: 11Jan2021; 2nd dose: 04Mar2021"; BNT162b2 (Dose: 3rd , Date: 28Sep2021, Site and route of injection:, Anatomical site of injection: Left deltoid, Route of administration: Intramuscular, Batch/Lot number: 301558A), administration date: 28Sep2021, when the patient was 72-year-old, for COVID-19 immunization, reaction(s): "short lived apillary adenopathy". The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "short lived apillary adenopathy".  Additional information: Reported as, only side effect from vaccine was short lived apillary adenopathy or the side of the injection. Sender's Comments: Linked Report(s): PFIZER INC-202300066370 same patient and event, different dose number;
Sex: M
Vaccine: COVID19
Symptoms: Ejection fraction, Ejection fraction abnormal, Myocarditis
Clinical narrative: myocarditis; EF 70%; This is a spontaneous report received from contactable reporter(s) (Physician) from a sales representative. The reporter is the patient.  A male patient in his 60's received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 4; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 3; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: MYOCARDITIS (medically significant), outcome "unknown"; EJECTION FRACTION ABNORMAL (non-serious), outcome "unknown", described as "EF 70%". The patient underwent the following laboratory tests and procedures: Ejection fraction: 70 %, notes: EF 70% being evaluated. Therapeutic measures were taken as a result of myocarditis, ejection fraction abnormal.  Clinical course: Patient experienced myocarditis s/p receiving 3rd booster of Pfizer vaccine. EF 70% being evaluated and treated by a cardiologist specializing in Covid-19 related cardiac issues.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal association between the events and suspect drug BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: she got COVID last year and took PAXLOVID. She added that she got COVID again; she got COVID last year and took PAXLOVID. She added that she got COVID again; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "she got COVID last year and took PAXLOVID. She added that she got COVID again". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: She mentioned that she got COVID last year and took PAXLOVID. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: She passed away six weeks later; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death, medically significant), outcome "fatal", described as "She passed away six weeks later". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received. This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP)).  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.; Reported Cause(s) of Death: She passed away six weeks later
Sex: U
Vaccine: DTAP, TDAP
Symptoms: Medication error, No adverse event, Wrong product administered
Clinical narrative: patient who got Daptacel instead of Adacel with no reported adverse event; Initial information received on 09-Feb-2023 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional.  This case involves an unknown age /gender patient who got Daptacel (Diphtheria-15/tetanus/5 ac pertussis vaccine ) instead of adacel (diphtheria-2/tetanus/5 ac pertussis vaccine) with no reported adverse.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received suspect Diphtheria-15/tetanus/5 ac pertussis vaccine Suspension for injection (formulation) and Diphtheria-2/tetanus/5 ac pertussis vaccine (formulation) (strength, dose, batch number and expiry date were not reported) instead of adacel with no reported adverse event (wrong product administered) ( latency-same day)   Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: F
Vaccine: MNQ
Symptoms: Accidental exposure to product, Extra dose administered, No adverse event
Clinical narrative: inadvertently administered an extra dose with no reported adverse event; Initial information received on 10-Feb-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 18 years old female patient who reported  inadvertently administered an extra dose  of vaccine meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 02-Aug-2022, the patient received a  dose of suspect meningococcal A-C-Y-W135 (T CONJ) solution for injection vaccine 0.5 ml total lot U7447AC strength not reported via unknown route in unknown administration site. On 06-Feb-2023 she also received a dose of the same vaccine  0.5 ml lot U7447AC via unknown route in unknown administration site for prophylactic vaccination.  On 06-FEB-2023 the patient developed a non-serious inadvertently administered an extra dose with no reported adverse event (accidental exposure to product).  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event inadvertently administered an extra dose with no reported adverse event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Joint swelling
Clinical narrative: Quite difficult for her to walk; Right knee swelled up right after the shot; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Right knee swelled up right after the shot) and GAIT DISTURBANCE (Quite difficult for her to walk) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced JOINT SWELLING (Right knee swelled up right after the shot) and GAIT DISTURBANCE (Quite difficult for her to walk). At the time of the report, JOINT SWELLING (Right knee swelled up right after the shot) and GAIT DISTURBANCE (Quite difficult for her to walk) outcome was unknown.            Concomitant medication was not provided. Treatment information was not reported.   Reporter did not allow further contact
Sex: U
Vaccine: DTAPIPV
Symptoms: Injection site erythema, Injection site pruritus, Rash macular, Vaccination site reaction
Clinical narrative: experiencing red, itchy, softball sized blotches on their legs where quadracel was administered; experiencing red, itchy, softball sized blotches on their legs where quadracel was administered; experiencing red, itchy, softball sized blotches on their legs where quadracel was administered; Initial information received on 10-Feb-2023 regarding an unsolicited valid non-serious case received from  other health professional.  This case involves four patients (unknown age and gender) who experienced red, itchy, softball sized blotches on their legs where diphtheria-15/tetanus/5 hybrid AC pertussis/IPV (MRC5) vaccine [Quadracel] was administered.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.   On an unknown date, the patients received unknown dose of suspect diphtheria-15/tetanus/5 hybrid AC pertussis/IPV (MRC5) vaccine, Suspension for injection, (strength, frequency, lot number and expiry date: not reported) via unknown route in unknown administration site for immunisation.  On an unknown date the patient had experiencing red, itchy, softball sized blotches on their legs where quadracel was administered (vaccination site pruritus), (vaccination site erythema), (vaccination site rash) (unknown latency) following the administration of diphtheria-15/tetanus/5 hybrid AC pertussis/IPV (MRC5) vaccine   No lab data was reported.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was Unknown for all events.